GlaxoSmithKline Pakistan Limited

KASE:GLAXO Stock Report

Market Cap: PK₨44.0b

GlaxoSmithKline Pakistan Balance Sheet Health

Financial Health criteria checks 6/6

GlaxoSmithKline Pakistan has a total shareholder equity of PKR22.2B and total debt of PKR0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are PKR40.2B and PKR17.9B respectively. GlaxoSmithKline Pakistan's EBIT is PKR1.8B making its interest coverage ratio -2.2. It has cash and short-term investments of PKR3.1B.

Key information

0%

Debt to equity ratio

PK₨0

Debt

Interest coverage ratio-2.2x
CashPK₨3.07b
EquityPK₨22.24b
Total liabilitiesPK₨17.92b
Total assetsPK₨40.16b

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: GLAXO's short term assets (PKR26.9B) exceed its short term liabilities (PKR16.1B).

Long Term Liabilities: GLAXO's short term assets (PKR26.9B) exceed its long term liabilities (PKR1.8B).


Debt to Equity History and Analysis

Debt Level: GLAXO is debt free.

Reducing Debt: GLAXO had no debt 5 years ago.

Debt Coverage: GLAXO has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: GLAXO has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.